文献速递眼底病与葡萄膜炎

56岁以下视网膜中央静脉阻塞患者高凝状态的实验室评估

LABORATORY EVALUATION OF HYPERCOAGULABLE STATES IN PATIENTS WITH CENTRAL RETINAL VEIN OCCLUSION WHO ARE LESS THAN 56 YEARS OF AGE.
PubMed 文献 · Retina · 2018-01-01

这项回顾性观察性病例系列纳入1995年1月至2014年12月55例年龄低于56岁的视网膜中央静脉阻塞(CRVO)患者,在发病时检测高凝相关指标,并在24至205个月后评估高血压、肥胖、高脂血症、糖尿病、睡眠呼吸暂停和青光眼等危险因素。中位随访168.5个月,初始实验室检测结果与后续诊断的任何危险因素均无相关性(P > 0.05),作者对血栓倾向检测的价值提出疑问。

要点

  • 50例患者中14例(28%)在CRVO发病时至少有一项高凝检测阳性。
  • 随访结束时肥胖11例(22%)、高血压29例(58%)、高脂血症21例(42%)、糖尿病24例(8%)、睡眠呼吸暂停5例(10%)、青光眼8例(16%)。
  • 随访至少10年的36例中30例(83%)出现至少一种常见危险因素,无人发生血栓栓塞事件。

核心结论

  • 年轻CRVO患者的高凝实验室检测结果与后来出现的常见危险因素无相关性。
  • 研究结束时许多常见危险因素已存在,提示这些因素仍是该病的核心病因。
  • 由于长期随访中无患者出现进一步凝血或异常血栓,血栓倾向检测的价值受到质疑。

研究设计与样本

  • 回顾性观察性病例系列,1995年1月至2014年12月纳入55例年龄低于56岁的CRVO患者。
  • 发病时检测同型半胱氨酸、活化蛋白C抵抗、蛋白C活性、蛋白S活性、抗凝血酶III活性、抗磷脂抗体和抗心磷脂抗体。
  • 24至205个月后评估高血压、肥胖、高脂血症、糖尿病、睡眠呼吸暂停和青光眼等CRVO危险因素。
  • 采用双变量相关和逻辑回归分析初始实验室检测结果与CRVO危险因素诊断之间的相关性。

主要发现

  • 中位随访168.5个月;5例完成至少24个月随访,9例完成至少5年,36例完成至少10年,5例无随访或随访不足24个月。
  • 50例患者中14例(28%)在CRVO发病时至少有一项检测阳性。
  • 随访结束时,11例诊断肥胖(22%)、29例高血压(58%)、21例高脂血症(42%)、24例糖尿病(8%)、5例睡眠呼吸暂停(10%)、8例青光眼(16%)。
  • 随访至少10年的36例中,30例(83%)出现至少一种常见危险因素,无人发生血栓栓塞事件。
  • 在随访至少2年、5年或10年的患者中,检测结果与任何危险因素的诊断均无相关性(P > 0.05)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To investigate whether the results of early tests for hypercoagulability are correlated with the development of central retinal vein occlusion risk factors later in life and to evaluate the necessity of these tests in younger patients. METHODS: This was a retrospective, observational case series. From January 1995 to December 2014, 55 patients aged below 56 years with central retinal vein occlusion (CRVO) were enrolled in the study. Laboratory evaluations for homocysteine, activated protein C resistance, protein C activity, protein S activity, antithrombin III activity, antiphospholipid antibodies, and anticardiolipin antibodies were obtained at the onset of CRVO. After 24 to 205 months, the presence of risk factors for CRVO such as hypertension, obesity, hyperlipidemia, diabetes mellitus, sleep apnea, and glaucoma was determined. Bilateral correlation and logistic regression were performed to determine the correlations between the results of the initial laboratory tests and the diagnosis of CRVO risk factors. RESULTS: The median follow-up was 168.5 months. Five patients completed at least 24 months of follow-up, 9 patients completed at least 5 years, and 36 patients completed at least 10 years. Five patients had no or less than 24 months' follow-up. Fourteen of 50 patients (28%) had at least one positive test result at the onset of CRVO. At the end of follow-up, 11 patients had been diagnosed with obesity (22%), 29 with hypertension (58%), 21 with hyperlipidemia (42%), 24 with diabetes (8%), 5 with sleep apnea (10%), and 8 with glaucoma (16%). Among 36 patients with a minimum 10 years' follow-up, 30 (83%) developed at least one common risk factor, and none experienced any thromboembolic events. There were no correlations between test results and the diagnosis of any risk factors in patients with a minimum of 2, 5, or 10 years' follow-up (P > 0.05). CONCLUSION: The results of laboratory tests evaluating hypercoagulability in young patients with CRVO are not correlated with later-developed commonly known risk factors. Many of the common risk factors were present by the end of the study, suggesting that they still remain the core etiology for the disease. The value of the thrombophilic tests is brought into question, as none of the patients demonstrated further clotting or any unusual thrombi with long-term follow-up.

来源:Retina,查看原文。版权归原作者所有。

引用

  1. Liu Q, Lahey JM, Karlen R, et al. LABORATORY EVALUATION OF HYPERCOAGULABLE STATES IN PATIENTS WITH CENTRAL RETINAL VEIN OCCLUSION WHO ARE LESS THAN 56 YEARS OF AGE. Retina. 2018. PMID: 28613222. doi:10.1097/IAE.0000000000001661

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。